Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
(责任编辑:패션)
下一篇:Seoul shares edge down amid US slowdown woes; won sharply down
- ·Police turn to AI to predict crimes, drug tracking
- ·S. Korea's inflation grows faster, stays over 3 pct for third month in Oct.
- ·Biden picks top Asia aide as nominee for deputy secretary of state
- ·인재영입위원장에 이철규 내정…김웅 "윤심만 영입하겠단 것"
- ·PPP decides to lift membership suspensions of ex
- ·35 foreign individuals to be awarded for promoting Korean culture
- ·Exports log first rise in 13 months in sign of trade recovery for Korea
- ·Asiana Airlines to sell cargo biz to smooth merger
- ·Posco Future M to supply battery materials for LG
- ·Baekyangsa's Buddhist cuisine templestay teaches what it means to eat beyond taste
- ·Baekyangsa's Buddhist cuisine templestay teaches what it means to eat beyond taste
- ·Exports gain 2.2% from Nov. 1
- ·[News Focus] Why Kim Jong
- ·민주당 이상민 의원, 내주 與 혁신위와 대담…거취 정할지 주목
- ·NTCK to celebrate 100th Seoul performance of ‘The Orphan of Zhao’
- ·EcoPro, SK Ecoplant to build EV battery recycling plant in Hungary
- ·송영길엔 선 그은 이준석 "이낙연 싫어할 이유 없다, 긍정적"
- ·Unique indoor dating spots to warm your winter days
- ·송영길엔 선 그은 이준석 "이낙연 싫어할 이유 없다, 긍정적"
- ·Seoul shares open higher ahead of Nvidia results
- ·S. Korea maintaining stable LNG supply amid Israel
- ·Govt. working to restore administrative network after major disruption
- ·Seoul shares open lower on US tech slide
- ·[Today’s K
- ·[New in Korean] Kim Hye
- ·Baekyangsa's Buddhist cuisine templestay teaches what it means to eat beyond taste
- ·Yoon visits Busan after failed World Expo bid
- ·EcoPro, SK Ecoplant to build EV battery recycling plant in Hungary